
Regulatory30 May 2026, 11:01 pm
Ravelcare Ltd: No Deviation in IPO Fund Utilization for FY26
AI Summary
Ravelcare Ltd reports no deviation or variation in the utilization of funds raised through its Initial Public Offer (IPO) for the year ended March 31, 2026. The company confirms that the funds were utilized as per the objects stated in the Prospectus. This statement has been reviewed by the Audit Committee and taken on record by the Board at their respective meetings held on May 30, 2026. Ratan Chandak & Co LLP, Chartered Accountants, have certified the IPO fund utilization as on March 31, 2026, stating that it matches the audited books of accounts.
Key Highlights
- Ravelcare confirms no deviation in IPO fund utilization for FY26.
- Audit Committee and Board reviewed and approved the fund utilization statement.
- Ratan Chandak & Co LLP certified IPO fund utilization as per audited books.
- ₹115000 Lakh allocated for marketing and advertisement expenses.
- ₹780580 Lakh allocated for setting up a new manufacturing facility.
Price Impact
More from RAVEL